Objectives: Foetal bovine serum (FBS) is often the serum supplement of choice for in vitro human cell culture. This study compares the effect of FBS and autologous human serum (AuHS) supplement in human peripheral blood mononuclear cell (PBMC) culture to prepare secretome.
| INTRODUCTION
The regenerative potential of the secretomes of stem and progenitor cells has been reported to treat neuronal disorders, 1 vascular diseases 2 and cutaneous wounds. 3 The secretome used for regenerative medicine are generally prepared using different types of human cells such as adult stem cells, 4 freshly isolated healthy peripheral blood mononuclear cells (PBMC) 5, 6 and apoptosis induced PBMC.
7-9
In the preparation of secretome, foetal bovine serum (FBS) is commonly used as the serum supplement in cell culture. As a rich source of proteins, growth factors, hormones, lipids, vitamins, attachment factors and other important trace elements, FBS supports the survival and proliferation of cells during in vitro cell culture. 10 However, the composition of FBS varies from lot-to-lot. Again, Neu5GC present in FBS may trigger immune response in xenogeneic culture such as human cells. 11 As an alternative, serum-free supplements such as purified or recombinant proteins are used to produce secretome. [5] [6] [7] [8] [9] Compared to FBS, serum-free supplements maintain better safety, reproducibility and consistency of cells during in vitro culture. 12, 13 Nonetheless, the recombinant or purified protein supplements were known to regulate the composition of paracrine factors in secretome by modulating the autocrine and paracrine signalling pathways. 14 As an alternative to either FBS or serum-free supplements, the present study analysed the potential of autologous human serum (AuHS) for the production of regenerative paracrine factors in the secretome. The serum of a donor was used as the supplement to culture the PBMC, which were isolated from the blood of the same individual. Parallel cultures were maintained with either FBS supplement or without any serum supplement to compare the potential advantage of using AuHS.
| MATERIALS AND METHODS

| Ethics statement
In this study, blood samples were collected after acquiring informed written consents from the donors. The sample collection procedure was approved by the Medical Ethics Committee, Faculty of Dentistry, University of Malaya [Reference #DF RD1301/0012(L)].
| Preparation of serum and isolation of PBMC
Blood was collected from healthy male donors, aged 21-35 y (n = 7) having no history of: smoking, alcohol consumption, drug and/narcotics addiction, diagnosis of any inflammatory diseases either chronic or at least in the last 4 weeks, major surgical treatment in the last 1 y, and immunotherapy. Blood was collected from each donor in two steps: (i) 20 ml without any anticoagulant for serum preparation, and (ii) 30 ml in vacutainer containing sodium heparin (GmbH, Hamburg, Germany)
for PBMC isolation.
To prepare the serum, 20 ml of blood was transferred to a 50 ml centrifuge tube (BD Bioscience, Franklin Lakes, NJ, USA) and was left at room temperature for an hour to facilitate coagulation. Then the tube containing the coagulated blood was centrifuged at 400 × g for 15 min to collect crude serum in sterile centrifuge tube for a second round of centrifugation at 1800 × g for 15 min to remove cell debris or insoluble particles. The final serum supernatant was heat treated at 57 ± 2°C for 30 min to inactivate complement and used as AuHS supplement in the respective PBMC cultures.
To isolate PBMC, 10 ml of blood was transferred into a 50 ml centrifuge tubes (BD Bioscience) and diluted with equal volume of Dulbecco's phosphate-buffered saline (DPBS) without calcium and magnesium (Gibco, Grand Island, NY, USA). The diluted blood was then added into another 50 ml centrifuge tube (BD Bioscience) containing 15 ml of Ficoll-Paque Plus (GE Healthcare, Uppsala, Sweden) and centrifuged at 400 × g for 30 min with brake off. Buffy coat containing PBMC was collected and washed twice with DPBS by centrifugation at 200 × g for 10 min. After discarding the supernatant, the cell pellet was mixed with basal media (BM) consists of RPMI-1640 containing L-glutamine (Gibco) and 50 units/ml Penicillin-Streptomycin (Gibco). Cell number was counted using Trypan Blue (Gibco) dye exclusion method.
| Media preparation and culture
Isolated PBMC were cultured either in BM, or in BM with either 10%
(v/v) FBS (Gibco) or 10% (v/v) freshly prepared AuHS supplement.
PBMC were seeded in 12-well plates at a density of 5.5 × 10 5 cells/ ml in different media. The plates were stored at 37°C and 5% CO 2 in humidified chambers, and incubated up to 96 h.
| Cell viability assay
The number of live PBMC was counted using Trypan Blue (Gibco) dye exclusion method at every 24 h interval until 96 h. The number of live cells was recorded as mean percentile (±SE) of increase or decrease in respect to the initial seeding number.
| Preparation of cytospin slides of PBMC
After 24 and 96 h of initial incubation, PBMC were harvested, washed twice using DPBS (Gibco) and the pellets were resuspended in 10% FBS (Gibco) containing DPBS (Gibco) to obtain 5 × 10 5 cells/ml. PBMCs were attached on poly-L-lysine coated slides (Thermo Scientific Shandon, Cheshire, UK) using cytocentrifuge (Thermo Scientific Shandon) and dried overnight in desiccation chamber followed by fixation in ice cold absolute acetone (Sigma-Aldrich, Steinheim, Germany) for 5 minutes and drying at room temperature for 10-15 min.
| Differential count of PBMC
Acetone fixed air dried slides were stained using Giemsa stain (SigmaAldrich) for differential count. In brief, the slides were stained with 5%
Giemsa stain for 20 min; washed briefly using deionized water and left in vertical position to air dry at room temperature. The number of myeloid and lymphoid cells were counted using microphotographs taken by axiocam ERc5s (Carl Zeiss, Jena, Germany) attached with microscope (Carl Zeiss). Three randomly chosen fields from each slide were chosen for microphotographs and subsequent cell counting.
Differential count was presented as mean % of total cells ± SE.
| Paracrine factors profiling
Culture supernatants were harvested at 24 and 96 h to profile the composition of paracrine factors present therein. Luminex-based
ProcartaPlex human cytokine/chemokine 17plex immunoassay kit from e-Bioscience (affymetrix, e-Bioscience, Vienna, Austria) was used to analyse the presence or absence of 17 selected paracrine factors known to either stimulate or inhibit proliferation, migration and differentiation of different cell types including PBMC (Table S1 ).
| Immunocytochemistry
Cyotspin slides prepared using PBMC harvested at 24 hours were used for immunocytochemical staining of CXCR-4 and SDF-1. 
| Molecular network analysis
The corresponding Entrez Gene ID of the selected 17 paracrine fac- Fisher's exact test indicate significant association (P = .05).
| Data analysis
Except for molecular network analysis, all other data were analysed using ANOVA and Tukey's HSD post-hoc (SPSS version 22). The significant level was set at P < .05.
| RESULTS
| Cell viability
At 24 h of incubation, the number of viable PBMC in FBS and AuHS 
| Differentiation
On the basis of morphology, PBMC were divided into two groups: 
| Paracrine factors profile in the secretomes
Seventeen paracrine factors were analysed in the secretomes at 24
and 96 h of incubation. The detected level of paracrine factors varied from one secretome to another (Table S2) .
| Comparative paracrine factors expression in the secretomes
| AuHS vs FBS secretome
At 24 h, significantly higher expressions of HGF (P < .05) and VEGF-A (P < .05) were detected in the AuHS secretomes compared to those in the FBS secretomes ( Figure 3 ). The HGF expression at 96 h was significantly higher in the AuHS secretomes compared to that in the FBS secretomes (P < .01) (Figure 3 ). Whereas the expression of EGF (P < .05) was significantly higher in the FBS secretomes when compared to the AuHS secretomes at 24 h ( Figure 3) . Notably, SDF-1A
was detected in the AuHS secretomes but not in the FBS secretomes either at 24 or 96 h ( Figure 3 ).
| AuHS vs BM secretome
At 24 h, expressions of BDNF (P < .01), G-CSF (P < .01), PDGF-BB (P < .05) and SDF-1A (P < .01) were significantly higher in the AuHS secretomes compared to those in the BM secretomes (Figure 3) .
At 96 h, expressions of BDNF (P < .01), G-CSF (P < .05) and HGF F I G U R E 2 Effect of serum supplement on the differentiation of peripheral blood mononuclear cells (PBMC). Differences in serum supplement did not show any effect on the differential count of PBMC until 96 h. (AuHS, autologous human serum; FBS, foetal bovine serum)
Comparison of the amount of paracrine factors in the secretomes of peripheral blood mononuclear cells (PBMC). Difference in the amount of paracrine factors namely, brain-derived neurotrophic factor (BDNF), epidermal growth factor (EGF), granulocyte colony stimulating factor (G-CSF), hepatocyte growth factor (HGF), platelet-derived growth factor beta (PDGF-BB), stromal cell-derived factor-1A (SDF-1A), vascular endothelial growth factor A (VEGF-A) and interleukin 6 (IL-6) in the secretomes prepared from PBMC that were cultured with either autologous human serum (AuHS), foetal bovine serum (FBS) or without any serum supplement i.e., in basal medium (BM) at 24 h and 96 h of incubation. (* = P < .05, ** = P < .01, n = 6) (P < .01) were significantly higher in the AuHS secretomes compared to those in the BM secretomes ( Figure 3) . Whereas, only VEGF-A expression was significantly higher in the BM secretomes compared to that in the AuHS secretomes both at 24 (P < .05) and 96 h (P < .01) (Figure 3 ).
| FBS vs BM secretome
At 24 h, the expression of EGF (P < .05), G-CSF (P < .05) and IL-6 (P < .05) were significantly higher in the FBS secretomes compared to those in the BM secretomes (Figure 3) . At 96 h, the expression of BDNF (P < .05), PDGF-BB (P < .01) and IL-6 (P < .05) were significantly higher in the FBS secretomes compared to those in the BM secretomes (Figure 3 ). The expression of VEGF-A in the BM secretomes was significantly higher (P < .01) compared to that in the FBS secretomes both at 24 and 96 h (Figure 3 ). Unlike in FBS secretomes, SDF-1A was detected in BM secretomes both at 24 or 96 h of incubation (Figure 3 ).
| Immunocytochemistry
A markedly higher expression of both SDF-1 and its receptor, i.e., CXCR-4 was detected in the PBMC that were cultured in AuHS supplemented media compared to that cultured in FBS supplemented media ( Figure 4 ). Prominent colocalization of SDF-1 and its receptor CXCR-4 was also detected in the PBMC cultured in AuHS supplemented media (Figure 4 ). (Table S3 ).
| Biological functions regulated by paracrine factors secreted from human PBMC
IPA was performed to identify the most significant molecular net- 
| Activation of high-mobility group box 1 protein (HMGB1) signalling pathway
IPA was also performed to identify the top most affected signalling pathways that could be influenced by the 17 paracrine factors analysed in the study. The top 10 pathways being affected (most to least)
by the analysed paracrine factors are listed in Table 1 . IPA predicted
F I G U R E 5 Predicted activation or inhibition of biological functions maintained by the 17 paracrine factors that were analysed in the autologous human serum (AuHS) and basal medium (BM) secretomes compared to the foetal bovine serum (FBS) secretome
No. Pathways −log P 
| DISCUSSION
Composition of paracrine factors in secretomes largely depends on the initial media composition as well as the type of cultured cells.
Animal serum, especially FBS, has been widely used as media supplement, as it provides proteins, growth factors, hormones, lipids, vitamins and other important trace elements in culture. 10 FBS, of which the exact composition is not well-defined, can be a vehicle of disease transmission, and can trigger immune response for its Neu5GC antigen. 11, 12 Serum free media supplemented with recombinant human protein or purified animal serum proteins have been used as an alternative to FBS in cell culture. 11, 12 However, a number of purified or To evaluate the impact of AuHS and FBS in secretome preparations, 17 paracrine factors commonly known to regulate proliferation, migration and differentiation related to tissue regeneration, were analysed in the respective secretomes (Table S1 ). However, the paracrine factors were analysed only at 24 and 96 h in the secretomes prepared using PBMC. It is well-known that the in vivo or in vitro half-life of any paracrine factor generally do not exceed more than a couple of hours. [17] [18] [19] Therefore, it was expected that the paracrine factors present in the sera at the time of separation would have minimum or no whereas in the vitreous of control nondiabetic patient SDF-1 was not detected. 24 Primary cultures of endothelial cells also expressed 50-130 pg/ml of SDF-1 in their secretome collected at 2, 24, 48 and 72 h of incubation. 25 In another in vivo study, ~40 pg/ml of SDF-1 in the plasma of the control hamster was observed, while ~100 pg/ml of SDF-1 was detected in the plasma of the animals treated with intramuscular VEGF. 26 In this study, 50-60 pg/ml of SDF-1A was detected in the both AuHS secretomes prepared at 24 and 96 h. This results are similar to those reported in the above-mentioned studies, hence we deduced that it could be adequate to initiate paracrine reactions.
Like AuHS secretome, SDF-1A was expressed in BM secretome as well. At 24 h of incubation the expression of SDF-1A in BM secretome (~20 pg/ml) was significantly (P < .01) lower than that of AuHS secretome (~50 pg/ml) ( Figure 3 ). This could be linked to the significantly lower number of viable cells in BM compared to AuHS supplemented media (Figure 1 ). Despite significantly lower number of viable cells, at 96 h SDF-1A expression in BM secretome was similar to AuHS secretome ( Figure 3 ). Intracellular expression of SDF-1A in monocytes and lymphocytes has been reported in several studies. 27, 28 In BM, percentage of dead cells was significantly higher than that of AuHS ( Figure 1B) . Hence, the presence of SDF-1A in BM secretome at 96 h could be secreted or released from the pool of live and dead cells, respectively. Along with poor cell viability (Figure 1 ), the composition of the secretome in BM was not superior compared to FBS or AuHS in term of paracrine factor composition (Table S2) Prediction on the biological function analysis ( Figure 5 ) also supports the in vitro PBMC viability and proliferation in the AuHS supplemented media (Figure 1) . Therefore, it is expected that AuHS secretome might favour in vivo regeneration of organ by increasing proliferation, viability, migration and homing of stem cells and progenitor cells (Table S5) . Besides the potential use in the regeneration of damaged organs, secretome rich in SDF-1 might also help the homing of transplanted hematopoietic stem cells in bone marrow. Hence, the functional network analysis was performed using IPA. A mild inhibition of NFκB, ERK1/2, FAK, AKT, HSP27, Fcer1 and Creb;
and a strong inhibition of Jnk, P13KP85, and collagenase type 1 were predicted in the AuHS secretome prepared at 96 h compared to that of 24 h (Figure 6 ). Notably, ERK1/2 is involved in liver regeneration 38, 39 and schwann cell proliferation; 40 Creb plays a positive role in liver regeneration; 41 AKT and FAK are involved in muscle regeneration; 42, 43 PI3K and AKT accelerates axonal regeneration, 44 as well as they play important roles in mesenchymal stem cells survival, proliferation, migration, angiogenesis, cytokine production and differentiation. 45 A mild activation of MEK and Nr1 h, and a strong activation of MAPK and CD3 were predicted in the AuHS secretomes prepared at 96 h.
Therefore, the AuHS secretome prepared at 24 h could be more beneficial to be used in regenerative therapy compared to that prepared at 96 h. However, further investigation is required to identify more specific molecular activation and inhibition of the identified functional molecular networks to propagate stem cells to be used for regenerative therapy.
| CONCLUSION
The AuHS supplement was shown to favour longer cell viability, and synthesis of more regenerative paracrine factors such as SDF-1A. In addition, HGF and VEGF-A which are involved in angiogenesis, cell proliferation, inhibition of apoptosis and immunoregulation were upregulated in the AuHS secretome. Thus, this study demonstrated that the regenerative potential of the secretome prepared with AuHS supplementation is higher.
